Sucralose inhibited cell survival through the activation of ER stress in human endothelial progenitor cells
PLOS One · 17.04.2026 · 21 (4) · e0347149
DOI: 10.1371/journal.pone.0347149 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 17.04.2026. Verfasst von Chia-Ying Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Show Chwan Memorial Hospital, Changhua, Taiwan. Hauptthemen laut MEDLINE: Endothelial Progenitor Cells, Endoplasmic Reticulum Stress, Sucrose, Sweetening Agents. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, China Medical University, Show Chwan Memorial Hospital.
Abstract (Originalsprache)
Sucralose, a widely utilized non-caloric sweetener, is frequently added to food and beverage products as a sugar substitute aimed at lowering energy consumption and reducing obesity-related health risks. However, epidemiological studies have indicated a possible association between high intake of sucralose and increased prevalence of coronary artery disease (CAD). Prior research has demonstrated that diminished levels of circulating human endothelial progenitor cells (hEPCs) are linked to a higher risk of CAD. Although sucralose is broadly consumed, its direct biological impact on hEPCs has not been comprehensively characterized. In this study, we investigated the cellular effects of sucralose on hEPCs using a variety of in vitro techniques, including assays for viability, migration, capillary-like tube formation, lactate dehydrogenase (LDH) release-cytotoxicity assay, and protein expression profiling by Western blotting. Our results revealed that increased concentrations of sucralose significantly impaired hEPCs viability, motility, and neovasculogenic function, accompanied by increased expression of markers associated with apoptosis, inflammasome activation, and pyroptosis. Mechanistic analysis further demonstrated that sucralose strongly activated endoplasmic reticulum (ER) stress/PERK pathways in these cells. Inhibition of ER stress via 4-phenylbutyric acid (4-PBA) substantially attenuated sucralose-induced cell death and reduced the expression of pyroptosis-related proteins and inflammasome markers. Taken together, these findings suggest that sucralose disrupts hEPCs function in part by triggering ER stress, which promotes both apoptotic and pyroptotic cell death programs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Show Chwan Memorial Hospital, Changhua, Taiwan.
- Doctoral Program in Tissue Engineering and Regenerative Medicine, National Chung Hsing University, Taichung, Taiwan.
- Research Assistant Center, Show Chwan Memorial Hospital, Changhua, Taiwan.
- Department of Post-Baccalaureate Medicine, College of Medicine, National Chung Hsing University, Taichung, Taiwan.
- Department of Food Science and Biotechnology, National Chung Hsing University, Taichung, Taiwan.
- Department of Internal Medicine, Nantou Hospital, Ministry of Health and Welfare, Nantou City, Taiwan.
ORCID-Profile: Feng-Yao Tang
Förderung
- National Science and Technology Council
- China Medical University
- Show Chwan Memorial Hospital
- Nantou Hospital of Ministry of Health and Welfare
Zitieren
APA
Li, C. Y., Lin, H. Y., Chiang, E. I., Hung, H. C., & Tang, F. Y. (2026). Sucralose inhibited cell survival through the activation of ER stress in human endothelial progenitor cells. PLOS One, 21(4), e0347149. https://doi.org/10.1371/journal.pone.0347149
Vancouver
Li CY, Lin HY, Chiang EI, Hung HC, Tang FY. Sucralose inhibited cell survival through the activation of ER stress in human endothelial progenitor cells. PLOS One. 2026;21(4):e0347149. doi:10.1371/journal.pone.0347149
BibTeX
@article{Li2026,
author = {Li, Chia-Ying and Lin, Hung-Yu and Chiang, En-Pei Isabel and Hung, Hung-Chang and Tang, Feng-Yao},
title = {Sucralose inhibited cell survival through the activation of ER stress in human endothelial progenitor cells},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {4},
pages = {e0347149},
doi = {10.1371/journal.pone.0347149}
}
EUVIMED